Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but They may be uncommon Within this malignancy in comparison to other lymphoid neoplasms. CHD2 aberrations and match ample to tolerate FCR therapy, should still be fantastic candidates with the latter, U